Xuanzhu Biopharmaceutical Co., Ltd. logo

Xuanzhu Biopharmaceutical Co., Ltd. (2575)

Market Closed
17 Sep, 08:00 AM
HKEX HKEX
9. 09
HKD
+0.96
+11.8081%
HKD
32.63B Market Cap
- P/E Ratio
- Div Yield
19.12M Volume
- Eps
8.13 HKD
Previous Close
Add Transaction
Day Range
8.13 11.72
Year Range
8.01 96.9
Want to track 2575 and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

Xuanzhu Biopharmaceutical Co., Ltd. (2575) Statistics

Valuation metrics

Market Cap 32.63B
Enterprise value 3.7B
Trailing P/E (ttm) -17.37
Forward P/E -
PEG ratio -0.15
Price/Sales (ttm) 36.67
Price/Book (mrq) 2.87
Enterprise Value/Revenue 31.65
Enterprise Value/EBITDA -19.93

Overview

Shares outstanding 517.95M
Float 142.8M
Shares short -
% Held by insiders 0.85%
% Held by institutions 0.01%
Average volume (10 days) 4.25M
Average volume (90 days) 1.8M

Price summary

52-Week low 8.01
52-Week high 96.9
Beta -
50-Day moving average 9.18
200-Day moving average 16

Financials

Fiscal year

Fiscal year ends 31 Dec 2025
Most recent quarter (mrq) 31 Dec 2025

Profitability

Profit margin -2.01%
Operating margin -1.82%

Operational effectiveness

Return on assets -0.13%
Return on equity -0.16%

Income Statement

Revenue (ttm) 59.93M
Revenue per share (ttm) 0.23
Quarterly revenue growth (yoy) 1.41%
Gross profit (ttm) 29.77M
EBITDA -238.05M
Net income to common (ttm) -284.21M
Diluted EPS (ttm) -0.45
Quarterly earnings growth (yoy) -

Balance Sheet

Total cash (mrq) 755.09M
Total cash per share (mrq) 1.13
Total debt (mrq) 748.99K
Total Debt/Equity (mrq) 0
Current ratio (mrq) 3.69%
Book value per share (mrq) 2.89

Cash Flow

Cash flow statement -243.06M
Levered free cash flow (LFCF) -197.58M